News

MedTech Executives Report Consequences of Poor Contract Management

MedTech Executives Report Consequences of Poor Contract Management

Consequences of Poor Contract Management in the MedTech Industry

The MedTech sector is grappling with serious challenges because of ineffective contract management. A recent survey by AcuityMD, a top technology provider for the commercial medical technology space, uncovered surprising insights regarding the revenue left untapped due to contract mismanagement. All participants noted that their organizations could greatly benefit from better usage of negotiated contracts, highlighting a vital area for improvement.

Key Findings from Medical Device Firms

This survey collected responses from over 150 MedTech professionals holding director-level positions or higher. Remarkably, two-thirds of these companies report that at least 70% of their annual income comes from contracts with health systems and various purchasing networks. Alarmingly, every participant felt they were missing potential revenue because of difficulties in managing these contracts. This reflects a clear need for improved strategies and tools.

Important Statistics on Contract Utilization

The survey presented several noteworthy statistics. For example, a striking 73% of executives from companies with over $1 billion in annual revenue anticipate that, in the next three years, around 90% or more of their earnings will depend on contractual agreements. This highlights the growing role that contracts play in generating revenue within the MedTech industry.

The Speed of Closing Contracts

Additionally, the findings showed a stark difference in how quickly on-contract opportunities are closed compared to off-contract ones. Survey respondents stated that closing on-contract opportunities can happen approximately 40% faster. This quicker pace underscores the efficiency gained through effective contract management.

Current Communication and Management Practices

When it comes to sharing contract information, respondents currently rely heavily on traditional methods. Almost all participants, 99%, reported using email to disseminate contract details. Additionally, 90% hold face-to-face meetings, and a significant 73% depend on calls and texts. These results illustrate an ongoing reliance on conventional means, which can often be time-intensive and inefficient.

Role of Technology in Contract Management

Notably, 96% of companies reported using spreadsheets for managing contracts, while 73% utilize Enterprise Resource Planning (ERP) systems. Though these tools are widespread, they may not effectively tackle the complexities of today's contract landscape. Looking ahead, 97% of those surveyed expressed intentions to hire more staff dedicated to contract management, reflecting a recognition of the need for expertise in this critical area.

Perspectives from Industry Experts

Insights from industry leaders reveal the underlying causes of these persistent challenges. Alex McLachlan, an important figure at Intellijoint Surgical, pointed out that ongoing consolidation in the U.S. healthcare system complicates the negotiation process. Since many orthopedic surgeons are now employed by hospitals, decision-making often shifts to corporate or administrative levels, making contract acquisition harder.

Tom Middleton, the Vice President of Strategic Growth at AcuityMD, also highlighted the inefficiencies found in current contract management practices. He remarked that simply increasing the number of staff to tackle these issues isn’t a long-term solution. Instead, he suggests embracing innovative technology that delivers contract intelligence, allowing sales teams to more easily identify and capitalize on on-contract opportunities.

Concluding Thoughts and Next Steps for AcuityMD

AcuityMD’s recent advancements in contract management technology offer hope in overcoming these hurdles. By introducing tools meant to streamline contract processes, they are working to minimize losses resulting from poor contract oversight. This effort isn't just about boosting efficiency; it's a critical step toward unlocking the full revenue potential within the MedTech industry.

Frequently Asked Questions

What is the key finding of the AcuityMD survey?

The survey revealed that all respondents believe their companies leave additional revenue untapped because of challenges in managing contracts.

How much revenue do medical device companies earn through contracts?

Two-thirds of the surveyed companies earn at least 70% of their revenue through contracts with health systems, IDNs, or purchasing networks.

What communication methods do companies utilize for contract management?

Companies mainly use email, meetings, and direct communications like calls and texts to share contract information.

How quickly can on-contract opportunities be closed?

According to the survey, on-contract opportunities can be closed around 40% faster than off-contract ones.

What innovations are being introduced by AcuityMD?

AcuityMD is developing contract management technology to improve the handling of contracts and reduce missed opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 166

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 125

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 121

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 180

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Datavault AI's Turbulent Boardroom Saga Escalates

Updated Category News Views 201

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 143

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 122

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 168

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Highlights of Week 17: Progress Under Trump’s Leadership

Updated Category News Views 424

Key Achievements in Week 17 Under Trump’s Leadership The recent developments from the Trump Administration have brought significant changes that resonate deeply with many Americans. Week 17 showcased not only triumph but also transformative strategies aimed at improving the lives of citizens. A notable highlight this week was President Trump's Executive Order focused on...

Continue Reading
Philips Shareholder Meeting Yields Positive Leadership Decisions

Updated Category News Views 359

Philips Shareholder Meeting: Key Outcomes from the AGM On a significant day for Royal Philips, shareholders gathered to approve a series of pivotal resolutions during the Annual General Meeting of Shareholders (AGM). The meeting highlighted a robust commitment to enhancing leadership structure and governance, reflecting the company’s dedication to ongoing improvement in...

Continue Reading
Growing Trends in the Lawn and Garden Consumables Market

Updated Category News Views 197

Overview of the Lawn and Garden Consumables Market The Lawn and Garden Consumables market is poised for significant growth, with a future projected value of approximately USD 38 billion by 2034. This sector includes essential products like fertilizers, seeds, pesticides, and more, serving various end-users from residential to commercial and industrial landscapes. Current...

Continue Reading
Weyerhaeuser Set for Q2 Earnings Release July 30

Updated Category News Views 59

Building Up to the Big Reveal There's always a buzz ahead of Weyerhaeuser's earnings releases, and this one's no different. On July 30, they're set to drop the curtain on their second quarter results for 2026. Now, you'd think that's standard fare, but when you've got a giant like Weyerhaeuser (NYSE: WY) on the table, investors sit up straight. With over 10 million acres...

Continue Reading
FINBOA Honored for Innovative Compliance Solutions at PayTech Awards

Updated Category News Views 178

FINBOA Celebrated for Excellence in Payments Compliance FINBOA, a front-runner in payments dispute automation and regulatory compliance, has been recognized as a finalist for the prestigious 2025 PayTech USA Awards. This nomination is for the category of Best Regulations & Compliance in Payments Solution, demonstrating the company’s commitment to innovation and...

Continue Reading